Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K E Elkind-Hirsch

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Placenta. Supplement|January 1, 1981
Presence of immunoreactive luteinizing hormone-releasing factor in hydatidiform mole as compared with normal human trophoblastic tissueR Osathanondh, K E Elkind-Hirsch
The Journal of Clinical Endocrinology and Metabolism|March 1, 1991
Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycleC T Valdes, K E Elkind-Hirsch
Fertility and Sterility|May 7, 1999
Pregnancy after treatment with the insulin-sensitizing agent troglitazone in an obese woman with the hyperandrogenic, insulin-resistant acanthosis nigricans syndromeK E Elkind-Hirsch, R B McWilliams
The Journal of Reproductive Medicine|September 1, 1996
Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppressionK E Elkind-Hirsch, C Anania, R Malinak
The Journal of Reproductive Medicine|January 1, 1987
Elevation of plasma immunoreactive luteinizing hormone releasing hormone in hyperprolactinemic-amenorrheic women on bromocriptine therapyK E Elkind-Hirsch, M P Platia, I Schiff
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failureK E Elkind-Hirsch, L D Sherman, R Malinak
Fertility and Sterility|July 1, 1996
Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonistE A Ruchhoft, K E Elkind-Hirsch, R Malinak
Fertility and Sterility|October 1, 1993
Insulin resistance improves in hyperandrogenic women treated with LupronK E Elkind-Hirsch, C T Valdes, L R Malinak
Fertility and Sterility|May 1, 1995
Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenismK E Elkind-Hirsch, C Anania, M Mack, et al.
Neuroendocrinology|April 1, 1990
Diabetes-induced alterations of reproductive and adrenal function in the female ratC T Valdes, K E Elkind-Hirsch, D G Rogers
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Placenta. Supplement|January 1, 1981
Presence of immunoreactive luteinizing hormone-releasing factor in hydatidiform mole as compared with normal human trophoblastic tissueR Osathanondh, K E Elkind-Hirsch
The Journal of Clinical Endocrinology and Metabolism|March 1, 1991
Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycleC T Valdes, K E Elkind-Hirsch
Fertility and Sterility|May 7, 1999
Pregnancy after treatment with the insulin-sensitizing agent troglitazone in an obese woman with the hyperandrogenic, insulin-resistant acanthosis nigricans syndromeK E Elkind-Hirsch, R B McWilliams
The Journal of Reproductive Medicine|September 1, 1996
Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppressionK E Elkind-Hirsch, C Anania, R Malinak
The Journal of Reproductive Medicine|January 1, 1987
Elevation of plasma immunoreactive luteinizing hormone releasing hormone in hyperprolactinemic-amenorrheic women on bromocriptine therapyK E Elkind-Hirsch, M P Platia, I Schiff
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failureK E Elkind-Hirsch, L D Sherman, R Malinak
Fertility and Sterility|July 1, 1996
Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonistE A Ruchhoft, K E Elkind-Hirsch, R Malinak
Fertility and Sterility|October 1, 1993
Insulin resistance improves in hyperandrogenic women treated with LupronK E Elkind-Hirsch, C T Valdes, L R Malinak
Fertility and Sterility|May 1, 1995
Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenismK E Elkind-Hirsch, C Anania, M Mack, et al.
Neuroendocrinology|April 1, 1990
Diabetes-induced alterations of reproductive and adrenal function in the female ratC T Valdes, K E Elkind-Hirsch, D G Rogers
Pageof 3